These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9426326)

  • 1. Proposal for a new model of breast cancer metastatic development.
    Demicheli R; Retsky MW; Swartzendruber DE; Bonadonna G
    Ann Oncol; 1997 Nov; 8(11):1075-80. PubMed ID: 9426326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour dormancy: findings and hypotheses from clinical research on breast cancer.
    Demicheli R
    Semin Cancer Biol; 2001 Aug; 11(4):297-306. PubMed ID: 11513565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures.
    Demicheli R; Retsky MW; Hrushesky WJ; Baum M
    Nat Clin Pract Oncol; 2007 Dec; 4(12):699-710. PubMed ID: 18037874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis.
    Allan AL; Vantyghem SA; Tuck AB; Chambers AF
    Breast Dis; 2006-2007; 26():87-98. PubMed ID: 17473368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seeing the invisible: how mathematical models uncover tumor dormancy, reconstruct the natural history of cancer, and assess the effects of treatment.
    Hanin L
    Adv Exp Med Biol; 2013; 734():261-82. PubMed ID: 23143983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy.
    Norton L
    Oncologist; 2005; 10(6):370-81. PubMed ID: 15967831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New concepts in breast cancer emerge from analyzing clinical data using numerical algorithms.
    Retsky M
    Int J Environ Res Public Health; 2009 Jan; 6(1):329-48. PubMed ID: 19440287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative insight into metastatic relapse of breast cancer.
    Hanin L; Pavlova L
    J Theor Biol; 2016 Apr; 394():172-181. PubMed ID: 26801873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstruction of the natural history of metastatic cancer and assessment of the effects of surgery: Gompertzian growth of the primary tumor.
    Hanin L; Bunimovich-Mendrazitsky S
    Math Biosci; 2014 Jan; 247():47-58. PubMed ID: 24211826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy.
    Demicheli R; Abbattista A; Miceli R; Valagussa P; Bonadonna G
    Breast Cancer Res Treat; 1996; 41(2):177-85. PubMed ID: 8944336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor dormancy and frailty models: A novel approach.
    Rancoita PM; Valberg M; Demicheli R; Biganzoli E; Di Serio C
    Biometrics; 2017 Mar; 73(1):260-270. PubMed ID: 27398936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling growth kinetics and statistical distribution of oligometastases.
    Withers HR; Lee SP
    Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kinetics of breast neoplasms].
    Surbone A; Norton L
    Minerva Med; 1994; 85(1-2):7-16. PubMed ID: 8152580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour.
    Demicheli R; Bonadonna G; Hrushesky WJ; Retsky MW; Valagussa P
    Breast Cancer Res; 2004; 6(6):R689-96. PubMed ID: 15535851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer dormancy can be maintained by small numbers of micrometastases.
    Willis L; Alarcón T; Elia G; Jones JL; Wright NA; Tomlinson IP; Graham TA; Page KM
    Cancer Res; 2010 Jun; 70(11):4310-7. PubMed ID: 20501854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell dormancy: implications for the biology and treatment of breast cancer.
    Fehm T; Mueller V; Marches R; Klein G; Gueckel B; Neubauer H; Solomayer E; Becker S
    APMIS; 2008; 116(7-8):742-53. PubMed ID: 18834416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.
    Demicheli R; Miceli R; Moliterni A; Zambetti M; Hrushesky WJ; Retsky MW; Valagussa P; Bonadonna G
    Ann Oncol; 2005 Sep; 16(9):1449-57. PubMed ID: 15956037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alternative approach for treatment of breast cancer.
    Swartzendruber DE; Retsky MW; Wardwell RH; Bame PD
    Breast Cancer Res Treat; 1994; 32(3):319-25. PubMed ID: 7865858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Putative growth characteristics of micrometastatic breast cancer.
    Chambers AF; Goss PE
    Breast Cancer Res; 2008; 10(6):114. PubMed ID: 19090969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.